pipette
ESEspañol

Bivalent, Copper-Mediated Amyloid-β Binding Disruptsthe Prion Protein's Neuroprotective Conformation

A. Smart, F. Pavlovici, K. Singewald, C. Marshak, C. Carollo, S. Kaplan, G. L. Millhauser

Preprint

In the authors' words

Emerging evidence shows that the cellular prion protein (PrPC) is a major receptor for Amyloid-{beta} (A{beta}) and that this aberrant interaction may influence the progression of Alzheimer's disease (AD). However, the molecular basis of this interaction remains poorly understood. Both proteins strongly bind Cu2+, and we previously discovered that PrPC, A{beta}30, and Cu2+ form a ternary complex at equimolar ratios. Here, using electron paramagnetic resonance (EPR) and nuclear magnetic resonance (NMR) spectroscopy with isotopically labeled proteins, we characterize the stoichiometry, stability, and molecular interactions of this ternary complex. We show that the complex forms preferentially at substoichiometric to equimolar Cu2+ concentrations yet remains stable at high Cu2+ ratios. The formation of the ternary complex is bivalent, requiring the previously identified A{beta}-binding domain on PrPC (residues 95-110) along with mutual Cu2+ coordination to the N-terminal octapeptide repeat domain in PrPC. Line broadening observed in A{beta}30 NMR experiments identifies its negatively charged N-terminal residues and central hydrophobic core (residues 17-21) as the primary PrPC binding sites. Through histidine mutation studies, we determine A{beta}30 coordinates Cu2+ primarily through His14. Critically, the ternary complex formation displaces Cu2+ from a specific His residue on the C-terminal domain of PrPC, disrupting the neuroprotective cis interdomain interaction that otherwise regulates the toxic effector N-terminal domain. Using segmentally isotopically 15N-labeled PrPC, we show that while the cis interaction is not fully eliminated by interaction with A{beta}, it becomes a disfavored conformational state. Together, these findings demonstrate how Cu2+ reinforces the PrPC-A{beta} interaction, in turn destabilizing PrPC's neuroprotective fold, offering a molecular mechanism for A{beta} accumulation at - and potential trafficking across - the plasma membrane.

Main resultLimitation the authors admit

Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.767124